# Prevention of Post-Operative Cardiac Arrhythmias

Study · id `cardio:ct-nct04234906` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04234906](<https://clinicaltrials.gov/study/NCT04234906>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04234906

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 870 participants.

## Technical summary

Registry record NCT04234906. Randomized; no masking; primary purpose treatment. Start 2023-01 (anticipated); primary completion 2023-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 870 participants (planned count; ClinicalTrials.gov record NCT04234906, source copy `cardio:ctgov-nct04234906-2022-03-15`, retrieved 2026-10-26)
- Planned start: 2023-01 (anticipated) (ClinicalTrials.gov record NCT04234906, source copy `cardio:ctgov-nct04234906-2022-03-15`, retrieved 2026-10-26)
- Primary completion: 2023-04 (anticipated) (ClinicalTrials.gov record NCT04234906, source copy `cardio:ctgov-nct04234906-2022-03-15`, retrieved 2026-10-26)
- Completion: 2023-08 (anticipated) (ClinicalTrials.gov record NCT04234906, source copy `cardio:ctgov-nct04234906-2022-03-15`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04234906-2022-03-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prevention of Post-Operative Cardiac Arrhythmias
- Acronym: POCA
- Condition: Cardiac; Dysrhythmia, Postoperative
- Condition: Congenital Heart Surgery
- Intervention (Drug): Dexmedetomidine
- Intervention (Drug): Magnesium Sulfate
- Intervention (Drug): Amiodarone
- Intervention (Drug): Procainamide
- Lead sponsor: Jeffrey Moak
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry intervention name matches this record: Amiodarone (`cardio:amiodarone`)

## Provenance

Content hash: 6a4de98f880ca9c9b876d55f39f9eab90febad18f959b029047acadc8b6d94c3
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
